Call for Abstracts
Abstract acceptance notification
Abstract acceptance notification has been sent. If you have not received the email yet, please contact fujiretina@jtbcom.co.jp.Abstract Submission Period
Abstract submission is open from October 15, 2021.
Abstract submission deadline:17:00, January 20 (Thursday), 2022 (Japan Standard Time, UTC+9)
Extended to 17:00, January 31 (Monday), 2022 (JST, UTC+9)
Extended to 17:00, February 28 (Monday), 2022(JST, UTC+9)
Closed. Thank you for a lot of submissions.
Notification will be listed by March 15 at our website.
Notification will be listed by March 15 at our website.
Travel Grant
New
For travel grant candidates:Travel grants will be extended to presenters who participate in e-poster session lively from overseas.
Don’t miss it and we are waiting for your apply!
FujiRetina encourages non-Japanese overseas ophthalmologists to submit abstracts. A number of abstracts will be selected as travel grant recipients by the Organizing Committee. 1,000 USD will be awarded to the first author of the submitted abstract. When selecting an appropriate category, please also select the travel grant application at the same time.
Note
- The travel grants will be presented to the grant winners after their abstract presentations at the meeting. All travel grant recipients must be at FujiRetina inperson.
- Travel grant recipients are responsible for making their own arrangements for transportation to the venue and accommodations during the meeting period.FujiRetina will not provide any stipends or reimbursements beyond the 1,000 USD.
- Results of the awards will be announced by email in February 2022.
- Practicing physicians and trainees are all eligible for thetravel grants.
Best Poster Awards
These awards are given to the three best posters presented at the meeting.
Poster winners will berecognized publicly at the Reception on April 23rd, 2022.
Poster winners will berecognized publicly at the Reception on April 23rd, 2022.
Conflict of Interest
Authors must disclose any conflicts of interest at the beginning of any presentation at FujiRetina. If the presentation is accepted, the category of conflict of interest and company names must be disclosed in the poster or presentation slides.
A. Presentations to Which These Rules are Applicable
These rules are applicable to all presentations, including those in Co-Sponsored Seminars, Free Paper, Panel Discussion, E-poster, etc.B. Conflicts of Interest Disclosures During Abstract Submission
Report potential conflicts of interest with companies within the last three years no matter whether it is directly related to the content of your presentation or not. If conflicts of interest are “present," enter the category and company names after each author's name in the entry field of “Conflict of Interest" on the abstract submission form. If there are no conflicts of interest, enter “category N." Confirm that the declaration is correct prior to the registration. Categories are as follows:1. Categories
F (Financial Support):
In the case where research expenses are supported or free research materials (including devices) or services (including sample measurements) are provided by companies* through the organization to which the author belongs.
* Companies denote both related companies and competitor companies. This is also the case for all subsequent categories.
In the case where research expenses are supported or free research materials (including devices) or services (including sample measurements) are provided by companies* through the organization to which the author belongs.
* Companies denote both related companies and competitor companies. This is also the case for all subsequent categories.
I (Personal Financial Interest):
In the case where the author is an investor in a company related to any products used and services are provided.
In the case where the author is an investor in a company related to any products used and services are provided.
E (Employee):
In the case where the author is an industry employee.
In the case where the author is an industry employee.
C (Consultant):
In the case where the author is currently, or was within the past three years, a consultant of a company.
In the case where the author is currently, or was within the past three years, a consultant of a company.
P (Patent):
In the case where the author holds a patent or is in the process of applying for a patent.
In the case where the author holds a patent or is in the process of applying for a patent.
R:
In the case where the author receives rewards* or travel expenses from a company related to any products used and services provided.
Rewards include salaries, travel fees, intellectual property rights, royalties, honoraria, shares, stock options, consultancy fees, lecture fees, expenses as a member of advisory committees and review panels, etc.
In the case where the author receives rewards* or travel expenses from a company related to any products used and services provided.
Rewards include salaries, travel fees, intellectual property rights, royalties, honoraria, shares, stock options, consultancy fees, lecture fees, expenses as a member of advisory committees and review panels, etc.
2. Class
Ⅰ．0 yen
Ⅱ．From 1 to less than 500,000 yen
Ⅲ．From 500,000 to 5,000,000 yen
Ⅱ．From 1 to less than 500,000 yen
Ⅲ．From 500,000 to 5,000,000 yen
Ⅳ．Over 5,000,000 yen
*Conflict of interest should be disclosed for the fiscal year during the previous three years when the author received the largest sum of money.
C. Disclosures in the Abstract and Slide Decks
Abstract:
The presence or absence of conflicts of interest to be disclosed for the author (including co-authors) will be automatically shown at the end of the abstract.
Slide and Poster:
If the authors have any conflicts of interest, the category and company names* should be described after the authors' names in the second slide for presentations, and at the bottom for posters.
* In the case of "Category P" (the author holds a patent or is in the process of applying for a patent), the company name need not to be described.
If all authors do not have any conflicts of interest to disclose, there will be a statement to the effect, “There are no conflicts of interest to be disclosed".
If all authors do not have any conflicts of interest to disclose, there will be a statement to the effect, “There are no conflicts of interest to be disclosed".
Privacy policy
"Names" and "contact addresses" provided to us at registration for the meeting shall be used for the purpose of contact from the secretariat, notification of acceptance or rejection, and any information related to the presentation. In addition, the “presenters' names," “affiliation names," “title" and “abstract text" shall be used for publication in the program/proceedings and on the website, but not for other purposes. The registration process for applications has been commissioned to c/o JTB Communication Design in order to facilitate management operations.
Inquiries
Secretariat of FujiRetinac/o JTB Communication Design, Inc., Co-Creation Department
JTB Bldg. 7F, 2-1-25 Kyutaromachi, Chuo-ku, Osaka 541-0056, Japan
Mail: fujiretina@jtbcom.co.jp